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1. Introduction 
Epidemiological studies indicate that in Europe, sudden cardiac death (SCD) is the cause of 
from 20 to 159 deaths per 100 thousand inhabitants / year. In the United States, therefore, 
die each year from 300 to 400 thousand people. Unfortunately, as shown by the results of 
clinical trials, the use of antiarrhythmic drugs doesn’t protect the majority of patients before 
the onset of malignant ventricular arrhythmias which are the main cause of SCD. 
Other methods of treatment aimed at eliminating the causes of arrhythmia, such as 
antiarrhythmic cardiosurgery or transvenous ablation of arrhythmias can be effectively used 
only in a narrow group of patients. 
Thus, the treatment of choice in treating people at risk of SCD became the implantation of 
cardioverter-defibrillator (ICD). The creator of the idea of this method of treatment was 
Mieczyslaw (Michel) Mirowski (1924-1990). In the sixties of the last century, he started work 
on the design of devices capable of cardiac rhythm track, and in case of serious ventricular 
arrhythmias automatically restore sinus rhythm. 
The first implantation of automatic defibrillators (without cardioversion) occurred in the 
Johns Hopkins Hospital in Baltimore in 1980. 
Evaluation of the effectiveness of the ICD in SCD preventing has been the subject of many 
studies. Based on the results, the indications for ICD implantation can be divided into 
secondary prevention, for patients after cardiac arrest with ventricular fibrillation (VF) or a 
previous episode settled ventricular tachycardia (VT) and the primary prevention, including 
patients without malignant arrhythmias. 
Immediately after ICD implantation, and after 3-7 days you need to confirm the correct 
positioning of defibrillation electrodes. This allows you to confirm the correct location and 
accuracy of programming. While the study conducted a few days after ICD implantation 
should confirm the effectiveness of the algorithm of therapy chosen by the proper detection 
of induced control ventricular fibrillation. There are two methods to identify and then a 
safety margin between defibrillation pulse energy of the programmed and actual energy 
www.intechopen.com
Cardiac Defibrillation  
– Prediction, Prevention and Management of Cardiovascular Arrhythmic Events 164 
required to terminate VF. These are: a test to verify the effectiveness of defibrillation and 
defibrillation threshold measurement. 
Verification test is relatively simple and involves initiation of ventricular fibrillation (with 
special functions ICD) and the interruption of the arrhythmia using a defibrillation pulse of 
a certain energy. This energy has to be correspondingly smaller (usually about half) than the 
maximum available under the ICD model so as to provide sufficient (double) safety margin 
taking into account possible fluctuations in defibrillation threshold in the future. After a 
successful test, defibrillation energy in the ICD is programmed at the highest available 
value. 
Defibrillation threshold (DFT) is the lowest energy allows to interrupt of VF. Measurement 
of DFT requires several times causing arrhythmia, and then interrupting by the pulse of 
different energy power. The usual method of DFT testing is protocol of gradually reduced 
defibrillation energy. The test is typically commenced from the defibrillation pulse energy of 
15-20 J. After each successful defibrillation is performed the next, using a pulse of energy 
usually lower about 10-20%. In this way, determines the highest energy, with which the 
successive VF is not interrupted. Another way of determining the DFT is to use the protocol 
with gradually increases defibrillation energy. In this case, the testing deffibrillation pulse 
has the energy gradually increased  (10-20%), ranging from 5-8 J until the determination of 
the lowest value allowing interrupt VF. 
The most commonly used algorithms of VF induction are the two: 
1. High-speed “burst-type” stimulation - depending on the model of ICD, shock for 
ventricular pacing pulse energy of several volts and frequencies of 30-50 Hz for a few to 
tens seconds (Fig. 1) 
2. “Shock on T” method - triggering the ICD pulse of energy from 0.5 J to a few J at the top 
of the T wave (Fig. 2) 
 
 
Fig. 1. An example of initiation of ventricular fibrillation by “burst-type” stimulation. 
Record of the Biotronik 1000 TMS programmer. Implantable cardioverter-defibrillator Belos 
VR - Biotronik.  Paper travel 25 mm / sec. 
Tip - Ring 
HV1 – HV2 
ECG 
Marker 
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Fig. 2. An example of initiation of ventricular fibrillation by “shock on T ” method. Record 
of the Biotronik 1000 TMS programmer. Implantable cardioverter-defibrillator Belos VR - 
Biotronik.  Paper travel 25 mm / sec. 
In some patients, repeated attempts to induce VF using both methods didn’t cause 
arrhythmia.1 Then you need to induction of VF by stimulation of burst-type beam pulses 
from the ICD connected with simultaneous induction of unsynchronised impulse from an 
external defibrillator.2,3 This method is sometimes called as a "shock,on burst".4   
1.1 Indications for ICD implantation 
The subject of many randomized controlled trials was to establish a factor to identify 
patients at risk of SCD. Because coronary artery disease is the basis of ventricular 
arrhythmias in 80% of cases and cardiomiopathies (especially dilated cardiomiopathy) in 
15%, that is why these diseases were a major subject of study in clinical trials of primary 
prevention. 
Although coronary heart disease and dilated cardiomyopathy are the most common cause 
of ventricular arrhythmias, European Society of Cardiology guidelines allow implantation 
of the ICD in primary prevention in patients with less recognizable diseases. An example is 
hypertrophic cardiomyopathy (HCM) with the associated additional risk factors such as 
syncope, family history, left ventricular wall thickness of over 30 mm, abnormal pressure 
response during exercise and paroxysmal ventricular tachycardia (Indications class IIa /C). 
Patients with HCM and episodes of ventricular fibrillation or ventricular tachycardia should 
undergo ICD implantation in secondary prevention. 
1 J Marker 
ECG 
HV1 – HV2 
Tip - Ring 
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In the course of arrhythmogenic right ventricular cardiomyopathy, ICD in primary 
prevention can be used in patients with syncope of unknown etiology or in the case of 
family history, and when the disease process coverage also includes the left ventricle 
(Indications class IIa/C) 
Also, a genetic disease such as long QT syndrome (LQTS), a polymorphic ventricular 
tachycardia-dependent catecholamine or Brugada syndrome may be the indication for 
prophylactic ICD implantation. In the case of LQTS, ICD can be implanted for primary 
prevention in patients with recurrent syncope despite beta-blocker therapy (Indications class 
IIa /B) or those without syncope but with known types of LQT2 and LQT3 treated as being 
particularly strongly associated with risk of SCD (Indications class IIb/B). Patients with 
Brugada syndrome with characteristic changes in the resting ECG, recurrent syncope, as well 
as those with polymorphic ventricular tachycardia dependent on catecholamines and syncope, 
may also be secured in the ICD in primary prevention (Indications class IIa /C). 
2. Indications for ICD implantation in primary prevention (Chart 1) 
Definitely relate to more potential patients than secondary prevention (Existing guidelines 
of the European Society of Cardiology) 
a. Prior myocardial infarction (after more than 40 days after MI)  
1. NYHA II or III, EF ≤ 35%, the expected survival time exceeds one year.  (Indication 
class I/A)  
2. NYHA I, EF ≤ 30-35%, the expected survival time exceeds one year.  (Indications 
Class IIa /B) 
b. Dilated cardiomyopathy noncoronarogenes 
1. NYHA II or III, EF ≤ 35% of the expected survival time exceeds one year. 
(Indication class I/B)  
2. NYHA I, EF ≤ 30-35%, the expected survival time exceeds one year. (Indications 
class IIb /C) 
c. Cardiomyopathy, whatever the reasons (coronary and noncoronary) 
NYHA III and IV, EF ≤ 35%, the duration of the QRS complex > 120 msec is recommended 
ICD implantation with the function resynchronisation stimulation (Indications Class I/A). 
3. Indications for ICD implantation in secondary prevention 
1. Past cardiac arrest caused by ventricular tachyarrhythmias in the mechanism 
irreversible or unknown. 
2. Ventricular tachycardia leading to unconsciousness. 
3. Syncope of unknown etiology, in patients in whom in electrophysiological examination 
there was haemodynamically not tolerated VT or VF. 
4. Cause of reversible and irreversible of cardiac arrest 
The cause is reversible, such as ventricular fibrillation, which occurred in the course of acute 
ischemia, myocardial infarction or acute phase of myocarditis is not an indication for ICD 
implantation, but the underlying disease requires treatment of any subsequent verification 
of indications. 
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(1) According to ACC / AHA / ESC 2006 guidelines for management of patients with ventricular 
arrhythmias and the prevention of sudden cardiac death5. 
(2) According to ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 
20086. 
Chart 1. Indications for ICD implantation for primary prevention of SCD. 
The cause is irreversible, eg electrolyte abnormalities associated with cardiac arrest or an 
adverse impact pharmacotherapy consisting of induction of arrhythmias. Irreversibility in 
these situations is the result of inability to confirm that any of these factors have been 
isolated and not accompanied to any other cause leading to arrhythmia. Furthermore, it's no 
possible to prevent with 100% certainty a recurrence of the situation. Thus, experts agree 
that in their current situation to propose ICD implantation for patient. 
5. Anesthesia for ICD patients 
ICD implantation is used in heavily loaded cases (see - the indications for implantation). 
Their ejection fraction (EF) is often reduced to 10-15%. Therefore, the anesthetic drugs used 
and their dosage must be carefully chosen. At the same time dose must be sufficient to run 
the entire test of the defibrillator. Can not be allowed to shallow sedation or anesthesia. 
In the Medical University of Gdansk, ICD is implanted since 1995. Initially, the ICD was 
implanted under general anesthesia. Prolonged surgery and prolonged anesthesia 
deteriorating general condition of patients. Since 1999, the ICD is implanted under local 
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anesthesia and deep sedation is performed to verify the proper functioning of the ICD and 
to determine the defibrillation threshold. 
6. Preparing the patient for deep sedation 
Patients presenting to the ICD implantation are being prepared for surgery by cardiologists.  
After determining cardiac indications, patients are evaluated in the ASA & NYHA scales. 
Due to the burden that is the heart muscle disease and often accompanies circulation failure, 
patients should be anesthetized by an experienced anesthesiologist. Before the procedure, 
EF is evaluated in ECHO-cardiography. In the operating room is used hemodynamic 
monitoring and oxygen therapy. It is advisable to monitor the depth of anesthesia because 
the ICD test is performed 2 - 4 times to set the parameters of defibrillation and monitoring 
its effectiveness. The interval between the performance of subsequent tests claims of at least 
2 - 3 minutes. You can’t afford to have shallowing of anesthesia. Anesthesia or deep sedation 
to the ICD test have to be short. Initiation of ventricular fibrillation isn't a painful process. 
Therefore, in this type of anesthesia isn’t used painkillers. 
7. Hypnotics used to the ICD test 
1. Etomidate (marketed as Amidate by Labeler)- carboxyl derivative of imidazole. Its 
anesthetic effect is a consequence of the depressant effects on the brain stem reticular 
creation, through stimulation of GABA. After etomidate injection some patients may 
appear myoclonus and dyskinesia. Etomidate causes luxury perfusion  the heart 
muscle.  Oxygen consumption by the myocardium under the influence of etomidate 
doesn't change, while the coronary circulation increases by 20%. This action is 
preferable to a thiopental actions on the myocardium, which also increases coronary 
blood flow but may also increase oxygen consumption by the myocardium. Etomidate 
doesn't affect heart rate, slightly decreases peripheral resistance, which increases 
cardiac output. Onset of action   after 15 - 45 sec. Duration of action 3 - 12 min. 
2. Sodium thiopental - (marketed as thiopental by Biochemie) - thiobarbiturate soluble in 
lipids. Its anesthetic effect is inhibiting formations in the brain stem reticular. The drug 
rapidly decreases blood pressure but slow injection causes compensatory mechanisms, 
and this decline is poorly defined. This drug has a beneficial effect on peripheral 
vascular resistance, because it increases slightly due to a compensatory increase in 
sympathetic activity. Heart rate after administration of thiopental is usually increased. . 
Thiopental exerts a direct negative inotropic effect on the myocardium. Reduces stroke 
volume. Onset of action after 20 sec. Duration of action 5 - 10 min. 
3. Propofol (marketed as Diprivan by Astra Zeneca) is a derivative of phenol. Changes in  
heart rate are less pronounced than after thiopental. Often, however, patients taking 
beta - blockers are observed bradycardia. Propofol causes hypotension, which is 
causing a negative inotropic effect and a decrease in peripheral resistance. Onset of 
action after 15 - 45 sec. Duration of action 5 - 10 min. 
4. Midazolam (marketed as Dormicum by Roche) - a water-soluble derivative of 
benzodiazepine. The action arises upon binding the drug to benzodiazepine receptors 
which enhance the inhibitory effect of GABA on the transfer of stimulus. The action of  
midazolam on the cardiovascular system is poorly expressed. Heart rate does not 
change or slightly increases. Myocardial contractility decreases slightly. Oxygen 
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consumption by heart muscle and blood flow don’t change. Onset of action after 30 - 60 
sec. Duration of  action 15 - 30 min. 
8. Monitoring depth of sedation 
1. EEG (Narcotrend) - this device is an attempt to automatic analysis of EEG. Induction of  
anesthesia is characterized by a decrease of frequency and amplitude of EEG waves. 
With  deepening anesthesia theta waves appear. Delta waves are characteristic of deep 
anesthesia.  The next stage is the occurrence of burst supression until the abolition of 
the electrical  activity of the brain characterized by the occurrence of isoelectric line.  
2. BIS - bispectral index - includes data of bispectral and conventional EEG analysis. 
Unites the different EEG parameters into a whole by presenting the average value of 
diversified parameters of bioelectrical activity of the brain. BIS is an absolute number 
from 0 to 100, where 100 represents the state of vigilance, and 0 is an electric silence 
(tab.1). With values of BIS from 83 to 89 amnesia occurs, and with values from 64 to 72 - 
loss of consciousness. 
 
BIS 100 the standby, preserved the memory 
BIS 65- 80 sedation 
BIS 40 – 65 moderate to profound loss of consciousness with amnesia recommended 
for general anesthesia 
BIS < 40 coma 
Table 1. The interpretation of the BIS value. 
3. AEP - auditory evoked potentials - assess the electrical activity of the brain caused by 
an acoustic stimulus. The severity of the waves depends on the state of consciousness. 
The smallest is asleep. The patient before anesthesia is placed in the ear headphones, 
which emit a loud signal. The patient's skin as opposed to the measure by BIS should be 
prepared. Abrasive tape rubs calluses, as to produce a skin reaction in the form of 
browning. 
4. Entropy of EEG - (Datex Ohmeda Entropy). Evaluation of depth of anesthesia consists 
of an analysis of two parameters: ST-state entropy - the value characteristic for the 
brain's electrical activity - EEG and RE - response entropy - includes EEG and 
electromyography of facial muscles. During deep anesthesia, these values didn't differ. 
Unexpected increase in RE in relation to the SE may be a sign of inadequate anesthesia. 
Among these depth of sedation monitoring techniques, least time-consuming and the 
simplest for interpretation is the BIS. Enhanced monitoring of patients for testing the ICD 
provides a good opportunity to assess the quality of anesthesia, while you carefully assess 
the condition of patients wake up after surgery. This monitoring is particularly important in 
patients at increased risk of general anesthesia. 
9. A study comparing etomidate, sodium thiopental and propofol
7
 
From the data presented in the literature shows that thiopental and propofol should be used 
in people with heart disease with caution. On the other hand, studies conducted in patients 
treated with electrotherapy because of arrhythmia, demonstrated safety of these 
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anesthetics8,9,10.We resigned from the use of etomidate because of the substantial degree of 
severe myoclonus which persisted even after waking patients, which is observed by Pacifico 
et al11.Before our study thiopental and propofol was used in smaller doses (3 mg / kg and 1 
mg / kg). Such proceedings require additional doses of medication between validation tests 
of the defibrillator-cardioverter. Determination of the dose of sodium thiopental 5 mg / kg 
and propofol 1.5 mg / kg allowed testing the ICD after a single dose in most patients. This 
has created a comfortable environment for staff and patients. Increasing the dose of drugs 
wasn't accompanied by an increased incidence of side effects such as apnea or prolonged 
time to recovery of full consciousness. 
The study group comprised 50 patients in whom anesthesia was performed using propofol 
(27 patients) or thiopental (23 patients). Ejection Fraction (EF) was assessed before the 
treatment by echocardiography. Patients weren't premedication. Monitoring of the patient 
in the operating room included ECG, blood pressure by the indirect method, pulse oximetry 
and bispectral index (BIS). In the operating room was used passive oxygen therapy by mask 
with oxygen flow 6 l / min. Anesthesia for this procedure was intravenous anesthesia 
without intubation.  For anesthesia was administered a single dose of propofol (1.5 mg/kg) 
or sodium thiopental (5 mg/kg) during 30 sec. Evaluation of the parameters was started 
after the administration of hypnotics.Statistical analysis was performed using Statistica 7.1 
PL (StatSoft, Tulsa, USA).The results, depending on the nature of their distribution, verified 
by test W (Shapiro  and Wilk) , presented as arithmetic mean (standard deviation) or 
median (range). To compare the data with normal distribution and comparable variances 
(Levene's test verification) was used T-test for independent variables, in the absence of 
homogeneity of variance was used T-test with separate variance estimation (Welch test). In 
cases of non-normality of variables, the comparison test was used Mann-Whitney test. 
Relationships between variables were tested using the R-Spearman's test of rank correlation. 
Adopted for significant p-value p<0.05. 
10. Results 
The results are shown in Table 2. 
 
Parameter Thiopental Propofol p 
Median Range Median Range 
EF ( % ) 30 15–75 40 15–70 0,55 
Loss of ciliary reflex (sec) 51 27-83 55 20-240 0,45 
Ciliary reflex recovery time (sec) 315 123–776 440 214-660 0,0099 
BIS output 98 94-99 98 89 –98 0,47 
BIS minimum 38 23–76 42 32 –82 0,05 
BIS minimum - time after the administration   of 
medicines 
93 50-312 140 54-570 0,04 
BIS after waking 75 59-84 72 59-89 0,74 
SpO2 output 98 96–100 98 95-100 0,17 
final SpO2  98 97-100 98 95-100 0,9 
Time from wake up to return to baseline BIS (sec) 397 181-841 253 122–549 0,0004 
Final BIS 98 94–99 98 89-98 0,47 
Table 2. Results of the variables studied. 
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EF ranged from 15 to 75% in both groups. The average age in both groups did not differ 
significantly. There was no difference in the disappearance of ciliary reflex in both groups 
(fig. 3), but its disappearance followed later in patients treated with propofol than in 
patients treated with thiopental (fig 4). 
 
 
Fig. 3. Ciliary reflex decay time (sec). 
 
 
Fig. 4. Ciliary reflex recovery time (sec). 
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Output BIS values in both groups were identical. There was a significant statistical 
difference in the minimal BIS value, and the time, in which the minimal BIS was achieved. 
Minimum BIS values were lower in patients receiving thiopental than in patients receiving 
propofol (fig 5). 
 
 
 
 
 
 
 
 
Fig. 5. BIS minimum. 
BIS value at which managed to make verbal-logical contact with the  patients were comparable 
in both groups (72 in patients receiving thiopental and 73 in patients receiving propofol).  Only 
the time of return to baseline BIS, was differed in both groups. It was significantly shorter in 
patients receiving propofol than in patients receiving thiopental (fig. 6). 
11. Discussion 
Implantable cardioverter defibrillators are implanted under general anesthesia 12,13,14 or 
under local anesthesia 11,15. Schematic procedure depends on the experience and standards 
of conduct 7. For short-term cardiac procedures are recommended short-acting drugs, 
without the depressive effects on the cardiovascular system 11-15. Clinical research 
comparing effects of etomidate, propofol and sodium thiopental, used for anesthetic during 
cardiac procedures didn’t show any hemodynamic differences in these patients 8,9,10.   Data 
from the literature shows that sodium thiopental and propofol should be used in people 
with heart disease with caution. On the other hand, studies in patients treated with 
electrotherapy because of arrhythmia, demonstrated safety of these anesthetics 8,9,10.  
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Fig. 6. Time of the return of baseline BIS. 
During anesthesia, there was no reduction in oxygen saturation in patients receiving 
propofol and in patients receiving sodium thiopental. Monitoring depth of anesthesia was 
performed using the BIS 16. The study of quality of sedation was made based on its 
evaluation. 16. In our study we observed that BIS values before and after anesthesia were 
almost identical. We noticed a statistically significant difference in the values of the 
minimum BIS. In patients who received sodium thiopental, this value was lower than the 
minimum value of BIS in patients who received propofol. Time after which the BIS has 
reached the minimum value was shorter in patients treated with thiopental (93 s) than in 
patients who received propofol (140s). The value of the BIS prior to anesthesia (98 v 98) was 
identical to the value of BIS after anesthesia (98 v 98). Baker et al in their clinical research 
showed same17. Although the BIS value before and after anesthesia were identical, but the 
BIS value at which managed to make a verbal-logical contact with the sick was lower by 
17.6% from baseline (72.4 v 73) in both groups.  
Fall asleep time of patients assessed as ciliary reflex decay time didn,t differ significantly in 
both groups, as well as the time between drug administration and awake. However, BIS 
recovery time after waking up to pre-sedation value was significantly shorter in patients 
receiving propofol. This moment was considered the end of the sedation and the patient 
returned to the clinic of cardiology. Similar acted Baker et al 17. Time since the recovery of 
verbal-logical contact with the patient until the return of BIS values to baseline was longer in 
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patients who received sodium thiopental (385 s) than in patients who received propofol. 
(253 s). Administration of each drug in a single dose was sufficient to realize  the ICD tests. 
Shorter BIS recovery time shows greater utility of propofol than thiopental for use in the 
sedation to  the ICD tests. 
12. Conclusions 
1. Propofol at a dose of 1.5 mg / kg and thiopental 5 mg / kg provide sufficiently deep 
sedation for defibrillator testing - cardioverter. 
2. Shorter BIS recovery time in patients receiving propofol demonstrates the increased 
usefulness of this drug for sedation to  the ICD tests. 
3. Anesthesia for ICD test using thiopental or propofol is safe for patients with low 
ejection fraction. 
4. During sedation with sodium thiopental and propofol, there was no significant 
hemodynamic differences in patients  undergoing ICD tests. 
5. BIS is the easiest ability to assess depth of anesthesia because of the ease of 
implementation and low invasiveness. 
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Millions of people throughout the world currently depend on appropriate, timely shocks from implantable
cardioverter defibrillators (ICDs) to avoid sudden death due to cardiovascular malfunctions. Therefore,
information regarding the use, applications, and clinical relevance of ICDs is imperative for expanding the body
of knowledge used to prevent and manage fatal cardiovascular behavior. As such, the apt and timely research
contained in this book will prove both relevant to current ICD usage and valuable in helping advance ICD
technology. This book is divided into three comprehensive sections in order to cover several areas of ICD
research. The first section introduces defibrillator technology, discusses determinants for successful
defibrillation, and explores assessments of patients who receive defibrillation. The next section talks about
predicting, preventing, and managing near catastrophic cardiovascular events, and research presented in the
final section examine special cases in ICD patients and explore information that can be learned through clinical
trial examinations of patients with defibrillators. Each chapter of this book will help answer critical questions
about ICDs.
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